Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma

BACKGROUND & AIMS: This study is designed to analyze survival benefit of (neo-) adjuvant radiotherapy to patients with T2-3N0M0 stage esophageal adenocarcinoma (EAC). METHODS: T2-3N0M0 stage EAC patients from 2004 to 2012 were searched from the Surveillance Epidemiology and End Results (SEER) da...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Song, Yaqi, Tao, Guangzhou, Guo, Qing, Yang, Xi, Zhu, Hongcheng, Wang, Wanwei, Sun, Xinchen
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008289/
https://ncbi.nlm.nih.gov/pubmed/26870996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7256
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires